NeuMoDx Molecular Inc., which offers high-throughput molecular diagnostics platforms for hospitals and reference laboratories, is submitting the coronavirus assay for Emergency Use Authorization (EUA) in the US. [Sidebar#MT126355]
The guidance allows some labs to start using COVID-19 laboratory-developed tests while awaiting US Food and Drug Administration approval under...





